158 related articles for article (PubMed ID: 11458813)
21. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
[TBL] [Abstract][Full Text] [Related]
22. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine.
Hoff PM; Valero V; Ibrahim N; Willey J; Hortobagyi GN
Cancer; 1998 Mar; 82(5):965-9. PubMed ID: 9486588
[TBL] [Abstract][Full Text] [Related]
23. Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma.
Zelek L; Barthier S; Riofrio M; Fizazi K; Rixe O; Delord JP; Le Cesne A; Spielmann M
Cancer; 2001 Nov; 92(9):2267-72. PubMed ID: 11745280
[TBL] [Abstract][Full Text] [Related]
24. Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure.
Martín M; Lluch A; Casado A; Garciía Carbonero I; de Paz L; Esteban C; Insa A; Alfonso R; García-Conde J; Diaz-Rubio E
Ann Oncol; 2000 Jan; 11(1):85-9. PubMed ID: 10690393
[TBL] [Abstract][Full Text] [Related]
25. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
26. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients.
Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF
Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898
[TBL] [Abstract][Full Text] [Related]
27. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
28. First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.
Vici P; Amodio A; Di Lauro L; Conti F; Gionfra T; Belli F; Lopez M
Oncology; 2000; 58(1):3-7. PubMed ID: 10644933
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer.
Lombardi D; Magri MD; Crivellari D; Spazzapan S; Paolello C; De Cicco M; Di Lauro V; Scuderi C; Veronesi A
Ann Oncol; 2000 Aug; 11(8):1041-3. PubMed ID: 11038043
[TBL] [Abstract][Full Text] [Related]
30. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I-II clinical trial.
Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
Cancer Chemother Pharmacol; 1999; 44 Suppl():S1-4. PubMed ID: 10602901
[TBL] [Abstract][Full Text] [Related]
31. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
32. A dose escalation study of leucovorin (LV) and 48-hour continuous infusion of 5-fluorouracil in combination with cyclophosphamide and vinorelbine in pretreated patients with metastatic breast cancer.
Kouroussis C; Kalbakis K; Androulakis N; Agelaki S; Vamvakas L; Malas K; Souglakos J; Vardakis N; Georgoulias V
Anticancer Res; 2004; 24(6):4217-21. PubMed ID: 15736475
[TBL] [Abstract][Full Text] [Related]
33. Vinorelbine combined with paclitaxel infused over 96 hours (VI-TA-96) for patients with metastatic breast carcinoma.
Cocconi G; Mambrini A; Quarta M; Vasini G; Bella MA; Ferrozzi F; Beretta MD
Cancer; 2000 Jun; 88(12):2731-8. PubMed ID: 10870055
[TBL] [Abstract][Full Text] [Related]
34. A phase II study of intravenous navelbine and doxorubicin combination in previously untreated advanced breast carcinoma.
Pawlicki M; Rolski J; Zaluski J; Siedlecki P; Ramlau C; Tomzak P
Oncologist; 2002; 7(3):205-9. PubMed ID: 12065792
[TBL] [Abstract][Full Text] [Related]
35. Clinical phase I and pharmacokinetic trial of vinorelbine administered as single intravenous bolus every 21 days in cancer patients.
Schilling T; Fiebig HH; Kerpel-Fronius S; Winterhalter B; Variol P; Tresca P; Heinrich B; Hanauske AR
Invest New Drugs; 1996; 14(4):371-8. PubMed ID: 9157072
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of weekly IV vinorelbine in first-line advanced breast cancer chemotherapy.
García-Conde J; Lluch A; Martin M; Casado A; Gervasio H; De Oliveira C; De Pablo JL; Gorostiaga J; Girón GC; Cervantes A
Ann Oncol; 1994 Nov; 5(9):854-7. PubMed ID: 7848890
[TBL] [Abstract][Full Text] [Related]
37. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
[TBL] [Abstract][Full Text] [Related]
38. Vinorelbine alternating oral and intravenous plus epirubicin in first-line therapy of metastatic breast cancer: results of a multicentre phase II study.
Serin D; Verrill M; Jones A; Delozier T; Coleman R; Kreuser ED; Mross K; Longerey B; Brandely M
Br J Cancer; 2005 Jun; 92(11):1989-96. PubMed ID: 15928659
[TBL] [Abstract][Full Text] [Related]
39. Paclitaxel and vinorelbine in anthracycline-pretreated breast cancer: a phase II study.
Michelotti A; Gennari A; Salvadori B; Tognoni A; Tibaldi C; Baldini E; Conte PF
Ann Oncol; 1996 Oct; 7(8):857-60. PubMed ID: 8922202
[TBL] [Abstract][Full Text] [Related]
40. Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.
Degardin M; Bonneterre J; Hecquet B; Pion JM; Adenis A; Horner D; Demaille A
Ann Oncol; 1994 May; 5(5):423-6. PubMed ID: 8075049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
